The prediction of early progressive disease in patients with hepatocellular carcinoma receiving atezolizumab plus bevacizumab
暂无分享，去创建一个
H. Shiraha | H. Hagihara | A. Takaki | Shinichiro Nakamura | K. Nouso | Y. Takeuchi | Nozomu Wada | H. Onishi | T. Adachi | Atsushi Oyama | S. Uematsu | K. Kariyama | H. Kobashi | K. Yabushita | Akio Moriya | S. Fujioka | H. Takabatake | S. Nakamura | Tatsuya Kikuchi | Yasuto Takeuchi